Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-25 @ 7:48 PM
Study NCT ID:
NCT01908335
Status:
COMPLETED
Last Update Posted:
2014-10-20
First Post:
2013-07-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C
Sponsor:
Beijing Kawin Technology Share-Holding Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-23
First Submit QC Date:
None
Study First Post Date:
2013-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-16
Last Update Post Date:
2014-10-20
Last Update Post Date Type:
ESTIMATED